AIDS Home > Lexiva and Pregnancy
In animal studies on Lexiva and pregnancy, the medicine increased the risk of miscarriages when it was given to pregnant rabbits. Due to this potential risk, healthcare providers should only prescribe Lexiva to pregnant women if the benefits outweigh any possible risks to the unborn child. If you are taking Lexiva and pregnancy occurs, be sure to notify your healthcare provider immediately.
Lexiva® (fosamprenavir calcium) is a prescription HIV medication. Based on information using the drug in animal studies, Lexiva may not be safe for use during pregnancy.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but that do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
In studies, giving Lexiva to pregnant rabbits increased the risk of miscarriages. However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category C medicine may be given to pregnant women if her healthcare provider believes that the benefits to the woman outweigh any possible risks to the unborn child.
If you are pregnant or are thinking of becoming pregnant while taking Lexiva, let your healthcare provider know. He or she will consider both the benefits and risks of using the drug during pregnancy before making a recommendation in your particular situation. Be sure to seek early prenatal care, as women with HIV or AIDS need special care, both for themselves and their babies.